A-Z pharma SRL
A-Z pharma reported total assets of €1.27m at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Aug 2026).
The score of A-Z pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -47 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
A-Z pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 01 Jul 2023
- Year ended 31 Dec 2021filed on 01 Sep 2022
A-Z pharma's financial analysis
- Solvency17.8%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of A-Z pharma
A-Z pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0689.800.949
- VAT number
- BE0689800949
- Peppol
- Registered · 0208:0689800949 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Feb 2018
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
A-Z pharma (SRL) has been based in Anderlecht since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 81,307 € and equity of 226,542 €; its revenue is not published. Its solvency stands at 17.8%, below the median of its sector (60.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to A-Z pharma
Companies in the same business, of comparable size and area, outside its group.
- Debersaques Y. Activities of holding companies Destelbergen · balance sheet €1.27m
- Brecht Spruytte Activities of holding companies Houthulst · balance sheet €1.27m
- Jade Holding Activities of holding companies Deinze · balance sheet €1.27m
- BLOCKHOUSE Consulting & Investments Activities of holding companies Deinze · balance sheet €1.28m
- Tenerga Activities of holding companies Woluwe-Saint-Lambert · balance sheet €1.27m
- PIU Plus Activities of holding companies Overijse · balance sheet €1.27m
- Cazeneuve Activities of holding companies Lommel · balance sheet €1.27m
- Snellewind Activities of holding companies Bocholt · balance sheet €1.28m
Frequently asked questions about A-Z pharma
What is the revenue of A-Z pharma?
A-Z pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of A-Z pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0689800949 for A-Z pharma, if the company is VAT-registered. Its company number (CBE) is 0689.800.949.
Where is the registered office of A-Z pharma?
According to the CBE register, the registered office of A-Z pharma is in 1070 Anderlecht.
What is the equity of A-Z pharma?
At the close of the 2025 financial year, the equity of A-Z pharma amounts to 226,542 €, a solvency of 17.8% of total assets.
Who manages A-Z pharma?
The register lists 1 active mandates at A-Z pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of A-Z pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →